PreludeDx (@preludedx) 's Twitter Profile
PreludeDx

@preludedx

Developers of DCISionRT, the first biological risk signature designed specifically for ductal carcinoma in situ (DCIS).

Your Biology, Your Decision®

ID: 935917226443530240

linkhttp://www.preludedx.com calendar_today29-11-2017 17:03:50

634 Tweet

250 Takipçi

339 Takip Edilen

PreludeDx (@preludedx) 's Twitter Profile Photo
PreludeDx
@preludedx

3 years ago

The study demonstrated that the #DCISionRT Residual Risk Subtype (RRt) identified #DCIS patients who had a much higher than expected recurrence risk following breast conserving surgery and radiation therapy. To read the release tinyurl.com/82bnkpte #PreludeDx #RedJournal

The study demonstrated that the #DCISionRT Residual Risk Subtype (RRt) identified #DCIS patients who had a much higher than expected recurrence risk following breast conserving surgery and radiation therapy. To read the release tinyurl.com/82bnkpte #PreludeDx #RedJournal